|
Concerns Increasing About New Omicron Variants of SARS-CoV-2
|
|
It is not yet clear if pharmacists will be busy for the next few months administering bivalent COVID-19 booster vaccines. If they are not, the risk of a difficult winter with high rates of SARS-CoV-2 infections greatly increases. Find out how much of the concern is being sparked by aggressive new Omicron variants.
|
|
|
Medicare Prescription Drug Spending Continues to Increase
|
|
|
The share of Medicare spending attributable to prescription drugs continues to rise, according to a new study published in the Journal of the American Medical Association. That percentage jumped from 24% in 2008 to more than 27% in 2019. Find out why the authors suggested those findings are likely to affect public policy in the future.
|
|
Apixaban Linked to Lower Stroke, Bleeding Risk
|
|
|
Rivaroxaban and apixaban are both oral direct factor Xa inhibitors and are used as alternatives to vitamin K antagonists. But that does not mean the two drugs work exactly the same, according to a new study that found lower risk for ischemic stroke, systemic embolism, and bleeding with apixaban when compared with rivaroxaban in atrial fibrillation/valvular heart disease patients. Read more.
|
|
|
Race a Factor in Use of Menopause Hormone Therapy
|
|
Pharmacists and other healthcare providers should provide more counsel about treatment alternatives to women with menopause symptoms. That is according to a new report that studied who received hormone therapy and how well they did on it. While white women are more likely to use hormone therapy and reported a quality-of-life improvement, that was not the case for other ethnic/racial groups. Read more.
|
|
.jpg)
